share_log

4: Statement of changes in beneficial ownership of securities-Director Klencke Barbara

4: Statement of changes in beneficial ownership of securities-Director Klencke Barbara

4：持股变动声明-董事 Klencke Barbara
美股SEC公告 ·  06/13 18:39
Moomoo AI 已提取核心信息
Barbara Klencke, associated with eFFECTOR Therapeutics, Inc. (EFTR), was involved in a transaction on June 13, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The absence of this information limits the ability to fully assess the impact of the transaction on the company's stock performance and investor decision-making.
Barbara Klencke, associated with eFFECTOR Therapeutics, Inc. (EFTR), was involved in a transaction on June 13, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The absence of this information limits the ability to fully assess the impact of the transaction on the company's stock performance and investor decision-making.
与eFFECTOR Therapeutics，Inc.（EFTR）有关的Barbara Klencke在2024年6月13日进行了交易。交易的具体细节，包括行动类型、状态、所涉及的股票数量、股票性质、交易价格和发帖后的持股情况未在公告中披露。缺乏这些信息会限制对交易对公司股票表现和投资者决策的完全评估。
与eFFECTOR Therapeutics，Inc.（EFTR）有关的Barbara Klencke在2024年6月13日进行了交易。交易的具体细节，包括行动类型、状态、所涉及的股票数量、股票性质、交易价格和发帖后的持股情况未在公告中披露。缺乏这些信息会限制对交易对公司股票表现和投资者决策的完全评估。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息